More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

A mixed bag of counterintuitive results hinders trial interpretation, but experts still see actionable results.

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research shows.

"Metformin was associated with a lowered risk of asthma attacks by approximately 30%," the researchers found. When patients ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

An Arkansas Legislative Council subcommittee has recommended that the state's health insurance plans for public school and state employees implement a diabetes management program that includes mental ...

The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...

Even as they agree that it’s important to address growing rates of diabetes and obesity, doctors in that field say Kennedy’s ...